Results 211 to 220 of about 17,057 (320)

Emerging Dissemination of blaCTX‐M‐65 in Bovine E. coli in Spain Associated With IncHI2 Plasmids

MicrobiologyOpen, Volume 15, Issue 3, June 2026.
The resistome in ESBL/AmpC‐producing E. coli in livestock was diverse and dominated by plasmid‐borne genes Detection of host‐independent dissemination of AMR determinants mediated by shared plasmid types First report in Spanish cattle of blaCTX‐M‐65 on IncHI2 plasmids, an under‐reported ESBL in Europe Identification of potentially zoonotic clones in ...
Medelin Ocejo, Beatriz Oporto, Ana Hurtado   +2 more
wiley   +1 more source

A versatile CRISPR-associated transposases-mediated toolkit for transcriptional regulation library. [PDF]

Nucleic Acids Res
Zhang Y, Zhou H, Xu X, Zhang K, Huang G, Fan F, Zhao D, Li Q, Zhu X, Zhang X.   +9 more
europepmc   +1 more source

VDJ recombination: a transposase goes to work.

Cell, 1998
Roth, David B, Craig, Nancy L
openaire   +2 more sources

Treponema denticola biofilm-induced expression of a bacteriophage, toxin-antitoxin systems and transposases.

Microbiology, 2010
H. Mitchell, S. Dashper, D. Catmull, R. Paolini, S. Cleal, N. Slakeski, Kheng H. Tan, E. Reynolds   +7 more
semanticscholar   +1 more source

The Role of N6‐Methyladenosine Modification in Health and Disease

MedComm, Volume 7, Issue 6, June 2026.
N6‐methyladenosine (m6A) is the most prevalent internal RNA modification in eukaryotes, acting as a pivotal epitranscriptomic regulator of RNA metabolism. This modification plays a dual role: it maintains physiological homeostasis under normal conditions but drives disease progression when dysregulated.
Linghuan Li, Yuanhai Sun, Wanfang Zheng, Lingqin Li, Yaqian Feng, Minyou Qi, Hanbing Li   +6 more
wiley   +1 more source

Transposon-based genome editing of industrial microorganisms: advances, challenges, and prospects. [PDF]

Synth Syst Biotechnol
Zhang Z, Huang Z, Wang Y, Li Z, Wen Z, Gu Y.   +5 more
europepmc   +1 more source

Regulation of Immune Checkpoints: From Molecular Mechanisms to Clinical Therapies

MedComm, Volume 7, Issue 6, June 2026.
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by unleashing antitumor immunity. This review comprehensively examines the molecular mechanisms underlying key immune checkpoints—including PD‐1/PD‐L1, CTLA‐4, and TIM‐3—and their clinical applications.
Qintao Ge, Liu Yu, Jiahe Lu, Aihetaimujiang Anwaier, Xiyue Xiao, Yonghao Chen, Dingwei Ye, Hailiang Zhang, Wenhao Xu, Wenbin Dai   +9 more
wiley   +1 more source

Correction: Archaea express circular isoforms of IS200/IS605-associated ωRNAs. [PDF]

Front Microbiol
Picinato BA, Franceschini-Santos VH, Zaramela LS, Vêncio RZN, Koide T.   +4 more
europepmc   +1 more source

Oxidative Stress and DNA Epigenetic Modifications in Cancer: Mechanisms and Targeted Therapeutics

MedComm – Oncology, Volume 5, Issue 2, June 2026.
Reactive oxygen species (ROS) modulate DNA methyltransferases (DNMTs), ten‐eleven translocation family proteins (TETs) and their cofactors, reshaping 5‐methylcytosine (5mC)/5‐hydroxymethylcytosine (5hmC)/5‐formylcytosine (5fC) landscapes and gene expression in cancer cells. In turn, epigenetic control of antioxidant and metabolic pathways feeds back on
Xishan Yang, Qitai Chen, YuJie Yu, Yi Zang, Rujia Zheng, Zhe Zhang, Shuaijun Lu, Li Zhou   +7 more
wiley   +1 more source

Correction: Genomic islands and plasmid borne antimicrobial resistance genes drive the evolution of high-risk, ST-131 uropathogenic E. coli NS30. [PDF]

BMC Genomics
Peketi ASK, Nagaraja V, Bulagonda EP.
europepmc   +1 more source